Supreme Court Ruling In Wyeth v. Levine: What’s The Liability For FDA?
Executive Summary
How the U.S. Supreme Court rules in Wyeth v. Levine could limit the number of product liability suits brought against drug companies. But how might the decision affect FDA, and by extension, the drug review process
You may also be interested in...
Rx Injury Claims May Grow After Court Finds Brand Liable For Generic Problems
The pharmaceutical industry is reeling from a court ruling that found brand name manufacturers are liable for the warnings on generic versions of their products
FDA Risk Communication Strategy May Include Overhaul Of Labeling Language
As FDA assesses its new risk management powers and overall drug safety strategy, it continues to focus on how to revise what has been its primary communications tool for decades - product labeling
Rx Injury Claims May Grow After Court Finds Brand Liable For Generic Problems
The pharmaceutical industry is reeling from a court ruling that found brand name manufacturers are liable for the warnings on generic versions of their products